EGFR and neoplasm: Epidermal Growth Factor Receptor (EGFR) activation is also associated with the upregulation of tumor immune escape markers (PD-1/PD-L1, CTLA4), and is associated with a slight increase in the risk of developing HYD (15, 16, 34).